Invasive Breast Cancer with Average HER2 Copy Number >= 4.0 and < 6.0: Risk Classification and Molecular Typing by a 21-Gene Expression Assay and MammaPrint plus BluePrint Analysis

LABORATORY INVESTIGATION(2022)

引用 0|浏览8
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要